Core Viewpoint - The public fund industry is undergoing a significant transformation, moving from an "active era" to a "passive era," with the A500 ETF battle symbolizing this shift. The competition among fund companies is intensifying as they vie for a long-term foothold in the market, especially with the upcoming introduction of options related to the A500 ETF [5][7][20]. Group 1: A500 ETF Competition - The A500 ETF saw a dramatic increase in total scale, rising by over 100 billion yuan in December 2025, despite a lack of significant retail investor activity [3]. - By the end of December 2025, the leading A500 ETF products included Huatai-PB with 494 billion yuan, followed by Nanfang Fund with 480 billion yuan, indicating a fierce competition among fund companies [4]. - The battle for A500 ETF dominance is critical for fund companies, as the winner will secure a long-term revenue stream, especially with the anticipated launch of related options in early 2026 [5][6]. Group 2: Fee Reform Impact - The fee reform initiated by the China Securities Regulatory Commission (CSRC) aims to reduce management and custody fees, resulting in an annual benefit of approximately 140 billion yuan to investors [8][10]. - The average comprehensive fee rate for public funds decreased from 1.41% in 2022 to 1.29% by the end of 2023, with further reductions expected in 2024 [10]. - The sales fee reform, effective from January 1, 2026, is projected to provide an additional annual benefit of around 300 billion yuan to investors, further tightening the profit margins for fund companies [11][13]. Group 3: Industry Challenges - The fee reductions have significantly compressed the profit margins for actively managed equity funds, leading to a decline in their attractiveness and a shift towards passive investment strategies like ETFs [14][18]. - The public fund industry is experiencing a shift in incentive structures, where fund managers are increasingly pressured to deliver excess returns, leading to a potential exodus of talent from active management roles [15][20]. - The competitive landscape is becoming increasingly polarized, with only a few fund companies likely to survive in the A500 ETF space, mirroring the market dynamics seen in the U.S. with the S&P 500 [18][19].

Core Viewpoint - The Hong Kong innovative drug sector continues its strong performance, with the Hang Seng Hong Kong Stock Connect Innovative Drug Index rising over 2%, indicating a bullish trend in the market [1] Industry Dynamics - Research Development: Innovent Biologics has received approval for its CTLA-4 monoclonal antibody "Daboshu" as the first domestically approved CTLA-4 inhibitor, filling a gap in the domestic dual immune new adjuvant therapy field [1] - Business Development: Ginkgo Bioworks has established a collaboration with AstraZeneca worth over $2 billion, setting a record for domestic clinical-stage small molecule anti-cancer drug collaborations [1] Market Activity - The Hong Kong Stock Connect Innovative Drug ETF managed by E Fund (159316) saw a significant increase in trading volume, exceeding 600 million yuan, indicating heightened investor interest [1] - The market's expectations for a potential interest rate cut by the Federal Reserve have increased, with the probability of a rate cut in March 2026 rising to over 40%, which may positively impact the Hong Kong innovative drug sector [1]

Market Performance - The Hong Kong Stock Connect innovative drug ETF managed by E Fund (159316) experienced a strong rebound today, rising by 3.3% with a trading volume increasing to 500 million [1] Core Drivers - Liquidity expectations have improved as the U.S. December non-farm payroll data fell short of expectations, leading to heightened market anticipation for a Federal Reserve interest rate cut, with the CME "FedWatch" indicating a 40.7% probability of a rate cut in March [2] Industry Updates - Research and Development Progress: Innovent Biologics' anti-CTLA-4 monoclonal antibody "Daboshu" has been approved for market launch as the first domestic drug of its kind [2] - Business Development Activity: GSK has entered into a collaboration with AstraZeneca worth over $2 billion, setting a record for domestic clinical-stage small molecule anti-cancer drug collaborations. The total transaction amount for outbound licensing in 2025 is projected to reach $135.655 billion [2]

Core Viewpoint - The major indices in the Chinese stock market showed positive performance at midday, with the Sci-Tech 100 Index leading the gains at 2.2% increase, indicating a bullish sentiment in the market. Group 1: Index Performance - The Sci-Tech 100 Index increased by 2.2% [1] - The CSI 500 Index rose by 1.1% [1] - The CSI 1000 Index saw an increase of 0.8% [1] - The CSI 2000 Index grew by 0.7% [1] - The ChiNext Mid-cap 200 Index experienced a rise of 0.5% [1] Group 2: ETF Information - The CSI 500 ETF tracks the CSI 500 Index, which consists of 500 stocks with a total market capitalization ranking below the top 300, and it had a rolling P/E ratio of 35.4 times with a valuation percentile of 67.8% [3] - The CSI 1000 ETF follows the CSI 1000 Index, made up of 1000 smaller, liquid stocks, with a rolling P/E ratio of 47.9 times and a valuation percentile of 70.2% [3] - The CSI 2000 ETF tracks the CSI 2000 Index, which includes stocks outside the CSI 1000 Index, and it had a rolling P/E ratio of 47.9 times [3] - The Sci-Tech 100 ETF focuses on 100 medium-sized, liquid stocks from the Sci-Tech Board, with over 75% of its composition in electronics, power equipment, and biomedicine [3] - The ChiNext 200 ETF tracks the ChiNext Mid-cap 200 Index, which consists of 200 medium-sized stocks from the ChiNext market, with over 40% in the information technology sector and a rolling P/E ratio of 109.5 times [4]

Core Viewpoint - The A-share market is expected to perform well due to the resonance of two factors: the restructuring of international order and China's industrial innovation by 2026 [1] Market Performance - As of the midday close, the CSI A500 index rose by 0.3%, the CSI A100 index increased by 0.1%, and the CSI A50 index saw a slight rise of 0.04% [1] - The trading volume of the A500 ETF managed by E Fund reached nearly 5 billion yuan during the half-day session [1] Future Outlook - According to China International Capital Corporation (CICC), the market is likely to experience an initial rise followed by stabilization, supported by active capital and elevated valuations [1] - Investors are advised to pay attention to increased volatility and the rhythm that aligns with fundamental performance [1]

Group 1 - The core viewpoint of the article highlights the performance of the Shanghai Stock Exchange Sci-Tech Innovation Board Growth Index, which consists of 50 stocks with high growth rates in revenue and net profit, predominantly in the electronics and communications sectors, accounting for over 65% of the index [3] - As of the midday close, the index experienced a rise of 1.4% [3] - The rolling price-to-earnings (P/E) ratio of the index stands at 198.2 times [3] Group 2 - The index was launched on July 23, 2020, and has shown significant growth since its inception [4] - The index is designed to reflect the performance of high-growth industries, with a focus on stable earnings and lower sensitivity to macroeconomic factors [4] - The article mentions that the index's valuation metrics are closely related to corporate profitability, making it suitable for industries with relatively stable earnings [4]

Market Overview - On January 7, A-shares saw a collective rise in the three major indices, with the Shanghai Composite Index increasing by 0.29%, approaching 4100 points. The total market turnover was approximately 1.85 trillion yuan, an increase of over 50 billion yuan compared to the previous day’s half-day trading [1]. Sector Performance - The sectors that performed well included storage chips, photoresists, rare earth permanent magnets, semiconductor equipment, non-ferrous metals, controllable nuclear fusion, high-speed copper cable connections, innovative drugs, and tourism and hotel sectors [1]. - Conversely, the sectors that experienced declines were oil and gas extraction and services, titanium dioxide, cross-border payments, pork, and military equipment [1]. Index Performance - The CSI 500 Index rose by 0.3% as of the midday close, while the CSI 300 Index saw a marginal increase of 0.03%. The ChiNext Index increased by 0.4%, and the STAR Market 50 Index rose by 1.1%. In contrast, the Hang Seng China Enterprises Index fell by 1.1% [1]. Index Valuation - The rolling P/E ratio for the CSI 300 Index was 14.5 times, placing it in the 69.1% valuation percentile since its inception in 2005 [2]. - The CSI 500 Index had a rolling P/E ratio of 17.5 times, with a valuation percentile of 76.9% since its inception in 2004 [2]. - The ChiNext Index had a rolling P/E ratio of 42.4 times, with a valuation percentile of 39.8% since its inception in 2010 [2]. - The STAR Market 50 Index had a rolling P/E ratio of 170.2 times, placing it in the 97.0% valuation percentile since its inception in 2020 [2]. Hang Seng Index - The Hang Seng China Enterprises Index, which consists of 50 large-cap and actively traded stocks listed in Hong Kong, saw a decline of 1.1%. Its rolling P/E ratio was 10.8 times, with a valuation percentile of 66.0% since its inception in 2002 [3].

Group 1 - The core viewpoint of the article indicates that the foundation for a bull market remains solid, with potential for profit improvement and capital inflow in the annual outlook [1] - As of the midday close, the Guozheng Growth 100 Index rose by 1.4%, while the Guozheng Value 100 Index and Guozheng Free Cash Flow Index both declined by 0.2% [1] - It is suggested to increase flexible asset allocation in anticipation of the spring market, as the technology sector typically shows significant excess returns during this period [1]

Core Insights - Nvidia has launched the new open-source VLA model Alpamayo at the CES conference, which will first be integrated into the new Mercedes-Benz CLA model [1] - The unveiling of Nvidia's global L4 autonomous driving and Robotaxi ecosystem indicates that the "chip + algorithm" integrated model is becoming the mainstream supply path for advanced intelligent driving [1] - The industry is entering a critical acceleration phase for commercial operation of L4 autonomous driving, with a resonance of trends both domestically and internationally, presenting opportunities for valuation recovery from technology development to scale profitability [1] Industry Overview - The Hang Seng Hong Kong Stock Connect Automotive Theme Index consists of 40 stocks related to the automotive industry within the Stock Connect range, covering leading companies in the Hong Kong automotive sector and core companies in the intelligent supply chain [1] - Investors can track investment opportunities in the intelligent driving industry chain through products like the E Fund Automotive ETF (159121) [1]

Core Viewpoint - The performance of oil funds has been lackluster compared to the significant gains seen in gold and silver funds, raising questions about when oil funds will rebound [1][2]. Group 1: Oil Fund Performance - In 2025, oil-related funds have shown poor performance, with many funds losing over 5%, while gold and silver funds have seen substantial gains, with some gold funds increasing by over 50% [1][3]. - Specifically, three oil funds have reported losses exceeding 10%, with the largest loss being over 13% for the E Fund Oil fund [3]. - Only two oil funds managed to maintain positive returns, one tracking an oil and gas industry index and the other actively selecting oil and gas stocks [3]. Group 2: Market Conditions - The Brent crude oil price has fluctuated between $50 and $80 per barrel in 2025, with the latest price at $63.12 per barrel as of January 6 [2]. - Factors contributing to the sustained low oil prices include increased production from OPEC and emerging oil-producing countries, along with high output from U.S. shale oil, leading to a surplus in supply [4]. - The demand for oil has been weak due to the rapid development of green energy and electric vehicles, coupled with a lack of growth in the chemical sector [4]. Group 3: Future Outlook - Analysts suggest that if the U.S. continues its loose monetary policy and domestic demand accelerates, there may be a window for oil prices to rise, but currently, the market remains in a weak state [5]. - Long-term investment in oil funds may yield significant returns if viewed through a 10 to 20-year lens, although uncertainties regarding future demand due to energy revolutions exist [5].